Giant Ventures Global LLP – Trademark Portfolio
Entity Type: 99
Giant Ventures Global LLP holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include GIANT IDEAS and GIANT VENTURES. The owner is based in London.
15 Penzance Place
Giant House
London W114PG , GB
Showing of trademarks Trademarks
Trademark Classifications
Giant Ventures Global LLP's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Giant Ventures Global LLP have?
Giant Ventures Global LLP has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Giant Ventures Global LLP file in?
Giant Ventures Global LLP files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Giant Ventures Global LLP's most well-known trademarks?
Giant Ventures Global LLP's registered trademark portfolio includes well-known marks such as GIANT IDEAS and GIANT VENTURES. These are among 2 currently registered trademarks in the portfolio.
What is Giant Ventures Global LLP's trademark registration success rate?
Giant Ventures Global LLP has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.